Pregnancy weight gain and breast cancer risk

BMC Women's Health

Volumn 4, Issue , 2004, Pages

  Kinnunen, Tarja I ^a,b   Luoto, Riitta ^a,b   Gissler, Mika ^c   Hemminki, Elina ^c   Hilakivi Clarke, Leena ^d  

^a UNIVERSITY OF TAMPERE   (Finland)

^b UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FINLAND; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNITY WARD; MEDICAL RECORD; MENARCHE; PARITY; PREGNANCY; RISK ASSESSMENT; WEIGHT GAIN;

EID: 13144302945     PISSN: 14726874     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6874-4-7     Document Type: Article

References (33)

1. Hilakivi-Clarke L, Cabanes A, Olivo S, Kerr L, Bouker KB, Clarke R: Do estrogens always increase breast cancer risk? J Steroid Biochem Mol Biol 2002, 80:163-174.
2. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S: Age at first birth and breast cancer. Bull World Health Organ 1970, 43:209-221.
3. Russo J, Romero AL, Russo IH: Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomarkers Prev 1994, 3:219-224.
4. Titus-Ernstoff L, Hatch EE, Hoover RN, Palmer J, Greenberg ER, Ricker W, Kaufman R, Noller K, Herbst AL, Colton T, Hartge P: Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer 2001, 84:126-133.
5. Enger SM, Ross RK, Henderson B, Bernstein L: Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer 1997, 76:118-123.
6. Wohlfahrt J, Melbye M: Maternal risk of breast cancer and birth characteristics of offspring by time since birth. Epidemiology 1999, 10:441-444.
7. Depue RH, Bernstein L, Ross RK, Judd HL, Henderson BE: Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, amd other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol 1987, 156:1137-1141.
8. Moore TR, Reiter RC, Rebar RW, Baker VV: Gynecology and Obstetrics New York: Churchill Livingstone; 1993.
9. Melbye M, Wohlfahrt J, Lei U, Norgaard-Pedersen B, Mouridsen HT, Lambe M, Michels KB: Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 2000, 92:1001-1005.
10. Richardson BE, Hulka BS, Peck JL, Hughes CL, van den Berg BL, Christianson RE, Calvin JA: Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998, 148:719-727.
11. Richardson BE, Peck JD, Wormuth JK: Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000, 9:1349-1355.
12. Hsieh C, Pavia M, Lambe M, Lan SJ, Colditz GA, Ekbom A, Adami HO, Trichopoulos D, Willett WC: Dual effect of parity on breast cancer risk. Eur J Cancer 1994, 30A:969-973.
13. Allen SH, Bennett JA, Mizejewski GJ, Andersen TT, Ferraris S, Jacobson HI: Purification of alpha-fetoprotein from human corad serum with demonstration of its antiestrogenic activity. Biochim Biophys Acta 1993, 1202:135-142.
14. Vakharia D, Mizejewski GJ: Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer. Breast Cancer Res Treat 2000, 63:41-52.
15. Acromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dorey LG: Androgens in preeclampsia. Am J Obstet Gynecol 1999, 180: 0-63.
16. Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE: Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 2002, 11: 61-368.
17. Troisi R, Weiss HA, Hoover RN, Potischman N, Swanson CA, Brogan DR: Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 1998, 9:641-647.
18. McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R: Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003, 21:1961-1966.
19. Petridou E, Katsouyanni K, Hsieh C, Antsaklis A, Trichopoulos D: Diet, pregnancy estrogens and their possible relevance to cancer risk in the offspring. Oncology 1992, 49:127-132.
20. Yang CY, Meng CL: Regulation of PG synthase by EGF and PDGF in human oral, breast, stomach, and fibrosarcoma cancer cell lines. J Dent Res 1994, 73:1407-1415.
21. Wuu J, Hellerstein S, Lipworth L, Wide L, Xu B, Yu GP, Kuper H, Lagiou P, Hankinson SE, Ekbom A, Carlstrom K, Trichopoulos D: Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur J Cancer Prev 2002, 11: 83-293.
22. Hemminki E, Gissler M, Toukomaa H: Exposure to female hormone drugs during pregnancy: effect on malformations and cancer. Br J Cancer 1999, 80:1092-1097.
23. Hemminki E, Gissler M, Merilainen J: Reproductive effects of in utero exposure to estrogen and progestin drugs. Fertil Steril 1999, 71:1092-1098.
24. Siega-Riz AM, Adair LS, Hobel CJ: Institute of Medicine maternal weight gain recommendations and pregnancy outcome in a predominantly Hispanic population. Obstet Gynecol 1994, 84: 65-573.
25. Carmichael S, Abrams B, Selvin S: The pattern of maternal weight gain in women with good pregnancy outcomes. Am J Public Health 1997, 87:1984-1988.
26. Yong LC, Brown CC, Schatzkin A, Schairer C: Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol 1996, 143:985-995.
27. Ostlund RE Jr, Yang JW, Klein S, Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996, 81: 909-3913.
28. Institute of Medicine: Nutrition during pregnancy, weight gain and nutrient supplements. Report of the Subcommittee on Nutritional Status and Weight Gain during Pregnancy, Subcommittee on Dietary Intake and Nutrient Supplements during Pregnancy, and Committee on Nutritional Status during Pregnancy and Lactation, Food and Nutrition Board. Washington DC, National Academic Press; 1990.
29. Rossner S, Ohlin A: Pregnancy as a risk factor for obesity: lessons from the Stockholm Pregnancy and Weight Development Study. Obes Res 1995, 3(Suppl 2):267s-275s.
30. Stock SM, Sande EM, Bremme KA: Leptin levels vary significantly during the menstrual cycle, pregnancy, and in vitro fertilization treatment: possible relation to estradiol. Fertil Steril 1999, 72:657-662.
31. Hu X, Juneja SC, Maihle NJ, Cleary MP: Leptin - a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002, 94:1704-1711.
32. Liehr JG: Is estradiol a genotox mutagenic carcinogen? Endocr Rev 2000, 21:40-54.
33. Olson CM, Strawderman MS: Modifiable behavioral factors in a biopsychosocial model predict inadequate and excessive gestational weight gain. J Am Diet Assoc 2003, 103:48-54.